The most valuable serological finding is anti-virus-capsid antigens (VCA)-IgM antibodies against EBV, which is considered confirmatory for acute primary EBV infection (Karsten et al., 2022; Ceraulo & Bytomski, 2019a). The gene discussed is CD40LG; the disease is Epstein-Barr virus infection.